You are an elite MBBS pharmacology professor, clinical pharmacologist, medical educator, pathophysiologist, and examination coach. Create a COMPLETE LEARNING NOTE for the topic(s) provided. The goal is NOT merely to summarize information. The goal is to teach the topic from absolute beginner level to MBBS examination mastery level. Assume the student has never seen the topic before. Write in extremely clear, plain English. Use language simple enough for a 9-year-old child to understand initially, then gradually build to MBBS level understanding. Never sacrifice understanding for brevity. Do not use unexplained jargon. Whenever a technical term is introduced: 1. Define it. 2. Explain why it matters. 3. Explain it using a simple analogy. 4. Explain it again in proper medical language. For every topic, use the following structure. --- SECTION 1: BIG PICTURE OVERVIEW Start with: "What problem does this drug class solve?" Explain: Why the disease occurs Why the microorganism survives What the drug is trying to achieve Where the drug acts Create a mental picture before discussing drugs. --- SECTION 2: BUILD THE FOUNDATION Before discussing drugs: Explain all background physiology. Explain all background microbiology. Explain all relevant pathology. Answer: What is normally happening? What goes wrong? Why does it go wrong? Where can drugs intervene? Use diagrams in text format where appropriate. Example: Bacterium ↓ Needs cell wall ↓ Cell wall keeps bacterium alive ↓ Drug blocks wall formation ↓ Wall becomes weak ↓ Bacterium dies --- SECTION 3: DRUG CLASS FRAMEWORK For each drug class explain: Definition Mechanism of action Why the mechanism works Spectrum of activity Important examples Clinical uses Adverse effects Contraindications Drug interactions Resistance mechanisms High-yield examination facts Common MCQs Most frequently tested concepts --- SECTION 4: TEACH USING ANALOGIES Create memorable analogies. Examples: Penicillin: "The bacterial cell wall is like a brick wall protecting a house. Penicillin prevents the workers from laying the bricks." Aminoglycosides: "The bacterial ribosome is like a factory producing products. Aminoglycosides force the factory to produce defective products." Sulfonamides: "Like cutting off a city's food supply." Always use vivid memorable analogies. --- SECTION 5: STEP-BY-STEP CLINICAL REASONING Teach how a doctor thinks. Example: Patient has pneumonia. Question 1: What organisms commonly cause it? Question 2: Which drugs cover those organisms? Question 3: Which drug reaches the lungs well? Question 4: What patient factors influence choice? Question 5: What adverse effects must be considered? Walk through reasoning systematically. --- SECTION 6: MEMORY TOOLS Create: Mnemonics Memory stories Visual memory tricks Drug comparison tables Rapid review boxes Focus only on useful mnemonics. --- SECTION 7: EXAMINER'S CORNER For each topic include: Most tested facts Most likely essay questions Most likely short notes Most likely viva questions Most likely MCQs Common traps students fall into How examiners phrase questions - SECTION 9: HIGH-YIELD REVISION SHEET End with: One-page revision summary Most important facts Must-know drugs Must-know toxicities Must-know mechanisms Must-know clinical uses Exam emergency facts --- SECTION 10: SELF-ASSESSMENT Create: 10 short-answer questions Provide answers with explanations. --- SPECIAL INSTRUCTIONS Do not assume prior knowledge. Teach before summarizing. Explain every mechanism step-by-step. Explain every adverse effect by linking it to physiology and pathophysiology. When discussing drugs, always answer: "What exactly is the drug doing?" "Why does that action help the patient?" "Why does that action produce the side effects?" "Why might resistance develop?" Use tables wherever helpful. Use comparison tables extensively. Make the note so comprehensive that an MBBS student can use it as their primary learning resource without needing another source for conceptual understanding. TOPICS TO COVER: Antiprotozoals

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Now I have enough material to write the comprehensive learning note. Let me compile it fully.

ANTIPROTOZOAL DRUGS

Complete MBBS Learning Note

From Absolute Beginner to Examination Mastery

SECTION 1: BIG PICTURE OVERVIEW

What Problem Does This Drug Class Solve?

Imagine tiny living creatures - too small to see without a microscope - that invade your body, set up home inside your blood cells, your gut, your liver, or even your brain, and eat you from the inside out. These creatures are called protozoa (singular: protozoan).

Protozoa are single-celled organisms that are more complex than bacteria. Think of bacteria as simple one-room huts, and protozoa as multi-roomed houses with their own electricity, plumbing, and security systems. This is why many antibiotics that kill bacteria have NO effect on protozoa.

The Big Picture Problem

Protozoal infections kill and disable millions of people every year, mainly in:

Tropical and subtropical regions (Africa, Asia, South America)
Areas with poor sanitation and contaminated water
Populations with weakened immune systems (HIV, transplant patients, newborns)

The challenge with antiprotozoals:

Protozoa are genetically similar to human cells (both are eukaryotes - explained below)
This makes it hard to find drugs that kill the parasite without harming the patient
Drug resistance is increasing rapidly
Many available drugs are quite toxic

The Goal

The goal of antiprotozoal drugs is to:

Kill the parasite or stop it from reproducing
At a dose that is tolerable to the human host
At a stage of the parasite's life cycle that is clinically relevant

SECTION 2: BUILD THE FOUNDATION

Part A: Understanding Protozoa - The Enemy

What Is a Protozoan?

Simple explanation: A protozoan is a tiny living animal - just ONE cell - but that one cell can do everything: eat, move, reproduce, breathe, and even hide from your immune system.

Medical explanation: Protozoa are eukaryotic organisms (meaning their cells have a nucleus - a central "command center" wrapped in a membrane). This makes them fundamentally different from bacteria (which are prokaryotic - no nucleus).

Why does this matter for drug treatment?

Feature	Bacteria (Prokaryote)	Protozoa (Eukaryote)	Human Cells (Eukaryote)
Nucleus	No	Yes	Yes
Ribosomes	70S (different from us)	80S (like us)	80S
Cell wall	Yes (most)	No	No
Mitochondria	No	Yes (some)	Yes
Size	~1 µm	5-100 µm	10-100 µm

Key insight: Because protozoa are eukaryotes (like us), drugs that target bacterial ribosomes or bacterial cell walls don't work on them. We need drugs that target something unique about the protozoan - a structure or pathway they have that we don't, or a structure they have in a slightly different form.

Part B: Classification of Medically Important Protozoa

Think of protozoa as divided into groups based on where they live in the body and how they move:

MEDICALLY IMPORTANT PROTOZOA
│
├── 1. BLOOD AND TISSUE PROTOZOA
│   ├── Plasmodium species (Malaria)
│   ├── Leishmania species (Leishmaniasis)
│   ├── Trypanosoma species (Sleeping sickness, Chagas disease)
│   └── Toxoplasma gondii (Toxoplasmosis)
│
├── 2. INTESTINAL/LUMINAL PROTOZOA
│   ├── Entamoeba histolytica (Amoebiasis)
│   ├── Giardia lamblia (Giardiasis)
│   ├── Cryptosporidium parvum (Cryptosporidiosis)
│   └── Trichomonas vaginalis (Trichomoniasis)
│
└── 3. OPPORTUNISTIC PROTOZOA (attack when immunity is low)
    ├── Toxoplasma gondii
    ├── Cryptosporidium parvum
    └── Pneumocystis jirovecii (technically a fungus but treated as protozoan)

Part C: Life Cycles - Why They Matter for Treatment

Key Concept: Most protozoa have multiple life stages - like a caterpillar, a cocoon, and a butterfly. Each stage may live in a different part of the body, or even in a different host (like a mosquito vs. a human). A drug may only kill ONE stage. This is why understanding the life cycle is crucial for choosing the right drug.

MALARIA - The Most Important Protozoal Disease

The Organisms

Plasmodium species cause malaria. There are 5 species that infect humans:

Species	Notes
P. falciparum	Most dangerous, causes cerebral malaria, drug resistance common
P. vivax	Second most common, causes relapses
P. ovale	Similar to vivax, also relapses
P. malariae	Mild disease, no relapses but can persist 20+ years
P. knowlesi	Primarily monkey pathogen, causes human disease in SE Asia

The Malaria Life Cycle (Step by Step)

Analogy: Think of malaria like a burglar who needs two houses to operate. First they plan their heist in one house (the mosquito), then they carry it out in another (the human).

STAGE 1: IN THE MOSQUITO (Sexual Cycle)
Female Anopheles mosquito bites infected person
→ Picks up GAMETOCYTES (sexual forms) from blood
→ Gametocytes mature in mosquito gut → SPOROZOITES form
→ Sporozoites migrate to mosquito's salivary glands

STAGE 2: ENTRY INTO HUMAN (Mosquito bites again)
→ Sporozoites injected into human bloodstream
→ Sporozoites travel to LIVER within 30 minutes
[This is the HEPATIC (Pre-erythrocytic) Stage]

STAGE 3: LIVER STAGE (Exoerythrocytic stage)
→ Sporozoites invade liver cells (hepatocytes)
→ Divide and multiply: LIVER SCHIZONTS form
→ In P. vivax and P. ovale: some form HYPNOZOITES
  (dormant forms that can "sleep" for months/years → RELAPSES)
→ Liver schizonts rupture → release MEROZOITES into bloodstream

STAGE 4: RED BLOOD CELL STAGE (Erythrocytic Stage)
→ Merozoites invade RED BLOOD CELLS (RBCs)
→ Inside RBC: Ring form → Trophozoite → Blood Schizont
→ Blood Schizont ruptures RBC → releases more merozoites
→ Cycle repeats every 48-72 hours → FEVER SPIKES

STAGE 5: SEXUAL FORMS
→ Some merozoites become GAMETOCYTES
→ If mosquito bites now, cycle restarts in mosquito

Clinical pattern: The rupture of RBCs causes the characteristic fever. In P. vivax/ovale: fever every 48 hours (tertian malaria). In P. malariae: every 72 hours (quartan malaria).

Drug Targets in the Malaria Life Cycle

Mosquito injects sporozoites
       ↓
[CAUSAL PROPHYLACTICS target here]
       ↓
LIVER STAGE (hepatic schizonts)
[TISSUE SCHIZONTICIDES target here - primaquine, atovaquone-proguanil]
       ↓
HYPNOZOITES (vivax/ovale only)
[Only PRIMAQUINE and TAFENOQUINE kill these - "radical cure"]
       ↓
RBC STAGE (blood schizonts) ← THE MAIN TARGET of most drugs
[BLOOD SCHIZONTICIDES - chloroquine, quinine, artemisinin, etc.]
       ↓
GAMETOCYTES
[GAMETOCIDES - primaquine kills P. falciparum gametocytes]

Key teaching point: The blood schizont stage is the only one that causes symptoms. That's why most antimalarial drugs are blood schizonticides.

AMOEBIASIS - The Gut Invader

Organism: Entamoeba histolytica

Life cycle (simple):

Contaminated food/water (CYSTS ingested)
→ Cysts resist stomach acid → reach large intestine
→ Transform into TROPHOZOITES (active feeding form)
→ Trophozoites can:
   a) Stay in gut lumen → ASYMPTOMATIC carrier (luminal amoebiasis)
   b) Invade gut wall → AMOEBIC DYSENTERY (flask-shaped ulcers)
   c) Enter bloodstream → EXTRAINTESTINAL amoebiasis
      - Amoebic liver abscess (most common extraintestinal site)
      - Rarely: brain, lung
→ Trophozoites form CYSTS → excreted → infect others

This is why TWO types of drugs are needed:

Luminal agents - kill amoeba in the gut lumen (e.g., diloxanide furoate, paromomycin)
Tissue agents - kill amoeba that have invaded tissues (e.g., metronidazole)

GIARDIASIS - The Waterborne Diarrhea

Organism: Giardia lamblia (also called G. intestinalis or G. duodenalis)

Transmitted by contaminated water ("Traveler's diarrhea")
Lives in small intestine (NOT large intestine like amoeba)
Causes: greasy, foul-smelling, floating stools; bloating; no blood in stool
Has TROPHOZOITE (active) and CYST forms
Treated with metronidazole, tinidazole, or nitazoxanide

LEISHMANIASIS - The Sandfly Disease

Organism: Leishmania species Vector: Female sandfly (Phlebotomus)

Forms of disease:

Form	Species	Features
Cutaneous	L. major, L. tropica	Painless skin ulcers
Mucocutaneous	L. braziliensis	Destroys nose, mouth, throat
Visceral (Kala-azar)	L. donovani	Most dangerous; fever, splenomegaly, pancytopenia

Life cycle:

Sandfly bites → injects PROMASTIGOTES (flagellated, extracellular form)
→ Promastigotes engulfed by macrophages
→ Transform into AMASTIGOTES (non-flagellated, intracellular form)
→ Multiply inside macrophages → destroy macrophages → spread
→ Sandfly bites infected person → picks up amastigotes → cycle continues

Important: Leishmania hides INSIDE macrophages. Drugs must penetrate these cells.

TRYPANOSOMIASIS - Two Very Different Diseases

African Trypanosomiasis (Sleeping Sickness)

Organism: Trypanosoma brucei gambiense (West Africa) or T. brucei rhodesiense (East Africa)
Vector: Tsetse fly
Stages:
- Stage 1 (Hemolymphatic): fever, lymphadenopathy, rash
- Stage 2 (Meningoencephalitic): neurological involvement, sleep disturbances, coma

American Trypanosomiasis (Chagas Disease)

Organism: Trypanosoma cruzi
Vector: Triatomine bug (Reduviidae; "kissing bug")
Stages:
- Acute: fever, myocarditis, meningoencephalitis
- Chronic: cardiomegaly, megaoesophagus, megacolon

TOXOPLASMOSIS - The Cat Parasite

Organism: Toxoplasma gondii (obligate intracellular parasite)
Definitive host: Cats (sexual cycle occurs in cats)
Intermediate hosts: Virtually all warm-blooded animals including humans
Transmission: Undercooked meat, cat feces, transplacental (mother to fetus)
Disease: Usually silent in immunocompetent people; severe in AIDS patients (toxoplasmic encephalitis) and fetuses (congenital toxoplasmosis)

SECTION 3: DRUG CLASS FRAMEWORK

DRUG GROUP 1: ANTIMALARIALS

1A. 4-AMINOQUINOLINES: Chloroquine and Amodiaquine

CHLOROQUINE

Definition: Chloroquine is a synthetic 4-aminoquinoline compound that is the oldest, cheapest, and best-understood antimalarial drug.

Simple analogy: The malaria parasite eats your red blood cell's hemoglobin. When it digests hemoglobin, it produces a toxic waste product called heme (a kind of iron-containing rubbish). Normally the parasite tidies up this rubbish by converting it into a harmless crystal called hemozoin. Chloroquine is like throwing a wrench into the parasite's waste disposal system. The toxic waste (heme) piles up and kills the parasite from the inside.

Mechanism of Action (detailed):

Parasite inside RBC:
1. Digests hemoglobin in its food vacuole (digestive sac)
2. This releases FREE HEME (ferriprotoporphyrin IX = FP)
3. Free heme is TOXIC to the parasite
4. Normally: Parasite polymerizes free heme → HEMOZOIN (harmless crystals)
5. CHLOROQUINE ENTERS the food vacuole (it accumulates there because
   the vacuole is acidic and chloroquine is a weak base - "ion trapping")
6. Chloroquine INHIBITS HEME POLYMERASE
7. Free toxic heme accumulates → damages parasite membranes → PARASITE DIES

Pharmacokinetics:

Route: Oral (also IV/IM for severe disease in some settings)
Absorption: Rapid and complete
Distribution: Very large volume of distribution (accumulates in tissues - especially liver, spleen, lungs, and kidneys)
Half-life: Very long (1-2 months) - explains why it can be used weekly for prophylaxis
Metabolism: Liver (CYP enzymes); active metabolite desethylchloroquine
Excretion: Mostly renal; urinary acidification increases excretion

Spectrum:

Blood schizonticide for ALL four Plasmodium species (in sensitive strains)
NOT effective against liver stages (tissue schizonts) or hypnozoites
Gametocidal against P. vivax, P. ovale, P. malariae (NOT P. falciparum)
Also effective against Entamoeba histolytica (amoebic liver abscess)

Clinical Uses:

Treatment of uncomplicated malaria (chloroquine-sensitive strains)
Prophylaxis in chloroquine-sensitive areas
Amoebic liver abscess (alternative to metronidazole)
Rheumatoid arthritis and Systemic Lupus Erythematosus (SLE) - disease-modifying drug

Adverse Effects:

Effect	Mechanism	Notes
Nausea, vomiting, abdominal pain	Direct GI irritation	Take with food
Pruritus (itching)	Very common in dark-skinned individuals	Especially Africans
Headache, dizziness	CNS effects
Retinopathy	Accumulates in retinal melanin; irreversible damage	Most feared long-term toxicity; need regular eye exams
Bleaching of hair	Inhibits melanin synthesis	Reversible
Cardiac toxicity	QT prolongation; rare but serious	Especially with IV use
Toxic psychosis	Rare	High doses

Contraindications:

Known retinopathy
Psoriasis (can precipitate severe attacks)
Epilepsy (can lower seizure threshold)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency (caution)
NOT contraindicated in pregnancy - safe to use

Drug Interactions:

Antacids: reduce absorption (separate by 4 hours)
Kaolin: reduces absorption
Amiodarone: additive QT prolongation

Resistance:

P. falciparum resistance to chloroquine is now widespread
Mechanism: Mutations in PfCRT (P. falciparum chloroquine resistance transporter) gene - the transporter pumps chloroquine OUT of the food vacuole before it can act
Geographic distribution: Resistance in sub-Saharan Africa, Southeast Asia, South America
P. vivax resistance emerging in Papua New Guinea and Southeast Asia

High-yield exam facts:

Chloroquine is a blood schizonticide only (NOT tissue schizonticide)
Pruritus is very common in Africans
Retinopathy is the most important long-term toxicity
Drug of choice for P. vivax, P. ovale, P. malariae (chloroquine-sensitive)
Safe in pregnancy
Mechanism: blocks heme polymerization (hemozoin formation)
Accumulates in acidic food vacuole by ion trapping

1B. 8-AMINOQUINOLINES: Primaquine and Tafenoquine

PRIMAQUINE

Simple analogy: If chloroquine is the soldier who fights the enemy in the open battlefield (blood), primaquine is the special forces unit that hunts down the enemy in their hidden bunkers (liver - especially the dormant hypnozoites).

Mechanism of Action:

Not fully understood
Generates reactive oxygen species (ROS) - essentially creates "rust" inside the parasite mitochondria, disrupting its energy production
Particularly effective against liver stages and gametocytes

Unique spectrum:

ONLY drug that kills HYPNOZOITES (dormant liver forms of P. vivax and P. ovale)
Therefore only drug that provides TRUE RADICAL CURE of vivax/ovale malaria (meaning it prevents relapses)
Also gametocidal against P. falciparum (prevents transmission)
Weak blood schizonticide

Clinical uses:

Radical cure of P. vivax and P. ovale (given with chloroquine; chloroquine kills blood stages, primaquine kills liver stages including hypnozoites)
Terminal prophylaxis (given after leaving malaria-endemic area to prevent relapse)
Eliminating P. falciparum gametocytes (to prevent transmission)
Alternative causal prophylaxis

The G6PD Problem - CRITICAL:

Simple explanation: Primaquine creates "rusting agents" (oxidants) inside cells. Normally, cells have a protective enzyme called G6PD (Glucose-6-phosphate dehydrogenase) that mops up this rust. If you don't have enough G6PD (G6PD deficiency - a genetic condition), primaquine's rust destroys your RED BLOOD CELLS. This is called hemolytic anemia.

Normal person:
Primaquine → oxidants formed → G6PD neutralizes oxidants → cells safe

G6PD-deficient person:
Primaquine → oxidants formed → NO G6PD to neutralize → 
→ Red blood cells oxidatively damaged → HEMOLYSIS
→ Hemolytic anemia: dark urine, jaundice, anemia

MUST ALWAYS test for G6PD deficiency before giving primaquine!

Adverse Effects:

Effect	Notes
Hemolytic anemia	In G6PD deficiency - most important; can be severe
Methemoglobinemia	Oxidant stress converts hemoglobin to methemoglobin (can't carry oxygen); cyanosis, headache
GI upset	Nausea, abdominal cramps
Leukopenia	Rare

Contraindications:

G6PD deficiency (relative; if must use, use low dose with close monitoring)
Pregnancy (may cause hemolysis in G6PD-deficient fetus)
Autoimmune conditions causing granulocytopenia

1C. ARYLAMINOALCOHOLS (Quinoline Methanols): Quinine, Mefloquine

QUININE

History: The oldest known antimalarial; derived from the bark of the cinchona tree (South America). Used since the 17th century. Still has a role today.

Mechanism: Similar to chloroquine - interferes with heme polymerization in the parasite's food vacuole. However, exact mechanism is not fully established.

Spectrum:

Rapid-acting blood schizonticide against all 4 Plasmodium species
Gametocidal against P. vivax and P. ovale (NOT P. falciparum)
NOT active against liver stages

Clinical Uses:

Severe falciparum malaria (IV or oral; IV artesunate now preferred where available)
Oral treatment of uncomplicated falciparum malaria (especially chloroquine-resistant)
Usually combined with doxycycline or clindamycin to shorten duration and reduce resistance

Adverse Effects - "CINCHONISM":

Cinchonism is the name given to the cluster of adverse effects caused by quinine and related drugs (quinidine, quinine). Think of it as "too much quinine syndrome."

Mnemonic: CINCHONISM = Tinnitus, Headache, Blurred vision, GI upset, Deafness

Symptom	Notes
Tinnitus (ringing in ears)	Most common symptom; dose-related
Headache
Nausea, vomiting, diarrhea
Visual disturbances	Blurred vision, altered color perception
Dizziness
Deafness	High doses

Serious Adverse Effects:

Effect	Notes
Hypoglycemia	Quinine stimulates insulin secretion from pancreas; especially dangerous in pregnant women and children
Cardiac toxicity	QT prolongation → torsades de pointes; especially with IV quinine (use IV quinine/quinidine with cardiac monitoring)
Blackwater fever	Massive hemolysis → hemoglobinuria → black urine; rare but life-threatening
Thrombocytopenia	Immune-mediated

Contraindications:

Optic neuritis
Tinnitus/deafness
Myasthenia gravis (neuromuscular blocking properties)
Hemolytic anemia
Use with caution in: pregnancy (hypoglycemia risk), cardiac disease

Drug Interactions:

Digoxin: quinine raises digoxin levels (inhibits P-glycoprotein and renal tubular secretion)
Anticoagulants: potentiates warfarin

MEFLOQUINE

Mechanism: Similar to quinine; blood schizonticide
Use: Chemoprophylaxis and treatment of chloroquine-resistant P. falciparum
Adverse effects:
- GI disturbance
- Neuropsychiatric effects: nightmares, anxiety, depression, hallucinations, psychosis - can be severe and lasting
- QT prolongation
Contraindications: Psychiatric disorders, seizure disorders, cardiac conduction abnormalities, pregnancy (first trimester)
Caution: Half-life is very long (about 21 days), so adverse effects persist after stopping drug

1D. ARTEMISININ AND ITS DERIVATIVES - The Most Potent Modern Antimalarials

Background: Artemisinin is derived from the Chinese herb Artemisia annua (sweet wormwood). The Chinese scientist Tu Youyou discovered its antimalarial properties and received the Nobel Prize in 2015 for this work.

Simple analogy: The malaria parasite contains iron in the heme from digested hemoglobin. Artemisinin is activated by this iron - like a chemical booby trap that the parasite itself triggers. Once activated, artemisinin releases a burst of free radicals that destroy the parasite from within.

Mechanism of Action:

1. Artemisinin enters the parasite's food vacuole
2. The ENDOPEROXIDE BRIDGE in artemisinin reacts with FREE IRON (heme iron)
3. This generates REACTIVE FREE RADICALS (carbon-centered radicals)
4. Free radicals alkylate (damage) vital parasite proteins
5. Parasite membrane proteins, hemoglobin-digesting enzymes, and other structures are destroyed
6. PARASITE DIES

Key point: Artemisinin is uniquely selective because the iron needed to activate it is only present in high concentrations inside malaria parasites (their food vacuole), not in normal human cells.

Derivatives (Artemisinins):

Drug	Route	Notes
Artesunate	IV, IM, oral, rectal	Drug of choice for severe malaria (IV artesunate); water-soluble
Artemether	IM, oral	Oil-soluble; combined with lumefantrine (Coartem) for uncomplicated malaria
Dihydroartemisinin (DHA)	Oral	Active metabolite of all artemisinins; combined with piperaquine
Artemisinin	Oral	Less used alone due to recrudescence

Unique features:

Fastest-acting antimalarials - reduce parasite load by ~10,000-fold per 48-hour cycle
Active against ALL stages of the blood cycle including young ring forms (other drugs miss these)
Active against multidrug-resistant P. falciparum
Gametocidal (reduces transmission)
Very short half-life (1-3 hours) - this is why they MUST be combined with longer-acting drugs (Artemisinin-Based Combination Therapy, ACT)

WHO-Recommended ACT Regimens:

Combination	Trade name
Artemether + Lumefantrine	Coartem
Artesunate + Amodiaquine	ASAQ
Artesunate + Mefloquine	ASMQ
Artesunate + Sulfadoxine-Pyrimethamine	AS-SP
Dihydroartemisinin + Piperaquine	Eurartesim

Adverse Effects:

Generally well tolerated
Nausea, vomiting, dizziness
Neurotoxicity at very high doses (animal studies; rare in humans at therapeutic doses)
Embryotoxic in animals - avoid in first trimester of pregnancy (artesunate is acceptable in 2nd/3rd trimester for severe malaria)
QT prolongation (lumefantrine more than artemisinins themselves)

Resistance:

Emerging resistance to artemisinins (K13 gene mutations in P. falciparum) first detected in Southeast Asia
Combination therapy is essential to prevent resistance

1E. ANTIFOLATES: Pyrimethamine, Proguanil, Sulfadoxine-Pyrimethamine (Fansidar)

Background: Malaria parasites cannot absorb folate from their environment - they MUST synthesize their own folate. Humans can absorb dietary folate. This key difference is exploited by antifolate drugs.

Simple analogy: Imagine a city under siege. The malaria parasite is like a factory that must build its own raw materials from scratch. Antifolate drugs cut the supply of the "building blocks" (folate) that the parasite needs to make DNA. The factory shuts down - the parasite can't replicate.

FOLATE SYNTHESIS PATHWAY IN MALARIA PARASITE:

PABA (para-aminobenzoic acid)
        ↓ [DHPS enzyme - blocked by SULFONAMIDES/DAPSONE]
DIHYDROPTEROATE
        ↓
DIHYDROFOLATE
        ↓ [DHFR enzyme - blocked by PYRIMETHAMINE/PROGUANIL]
TETRAHYDROFOLATE (active folate)
        ↓
PURINES for DNA synthesis
        ↓
PARASITE REPLICATION → BLOCKED

PYRIMETHAMINE:

Inhibits dihydrofolate reductase (DHFR) of the parasite (higher affinity for parasite enzyme than human DHFR)
Slow-acting (tissue schizonticide + blood schizonticide)
Synergistic with sulfonamides (blocks two sequential steps in same pathway)
Combined with Sulfadoxine as Fansidar (SP)
Combined with Sulfadiazine for toxoplasmosis

SULFADOXINE-PYRIMETHAMINE (Fansidar):

Used for chloroquine-resistant falciparum malaria
Intermittent preventive treatment in pregnancy (IPTp) in sub-Saharan Africa
Resistance widespread - limits use as first-line treatment

PROGUANIL:

A prodrug; converted to cycloguanil (active form) by liver CYP2C19
Cycloguanil inhibits parasite DHFR
Combined with Atovaquone as Malarone for treatment and prophylaxis
Proguanil itself also inhibits parasite mitochondria (independent of cycloguanil)

ATOVAQUONE-PROGUANIL (Malarone):

Atovaquone: inhibits parasite mitochondrial electron transport chain (cytochrome bc1 complex) → collapses mitochondrial membrane potential → disrupts folate synthesis
Proguanil: synergizes with atovaquone (and inhibits DHFR)
Used for: prophylaxis and treatment of chloroquine-resistant falciparum malaria
Advantage: starts and stops quickly (good for short-trip prophylaxis)
Disadvantage: expensive
Adverse effects: nausea, vomiting, abdominal pain, headache, mouth ulcers (proguanil)
Contraindication: Severe renal impairment; NOT recommended in pregnancy (insufficient safety data)

1F. SUMMARY TABLE - ANTIMALARIAL DRUGS

Drug	Class	Stage Active Against	Key Use	Key Toxicity
Chloroquine	4-aminoquinoline	Blood schizont, gametocyte (not falciparum)	Sensitive malaria; SLE; amoebic liver abscess	Retinopathy, pruritus
Primaquine	8-aminoquinoline	Liver stages (hypnozoites!), gametocytes	Radical cure P. vivax/ovale	Hemolysis in G6PD deficiency
Tafenoquine	8-aminoquinoline	Liver stages	Radical cure P. vivax	Hemolysis in G6PD deficiency
Quinine	Quinoline methanol	Blood schizont	Severe malaria (now replaced by artesunate)	Cinchonism, hypoglycemia, cardiac
Mefloquine	Quinoline methanol	Blood schizont	Prophylaxis/treatment chloroquine-resistant	Neuropsychiatric
Artesunate	Sesquiterpene lactone	All blood stages (fastest)	Severe malaria (IV), ACT partner	Generally safe; embryotoxic
Artemether	Sesquiterpene lactone	All blood stages	ACT (with lumefantrine)	QT prolongation (with lumefantrine)
Pyrimethamine	Antifolate (DHFR inhibitor)	Blood + tissue schizont	With sulfadiazine for toxoplasmosis	Megaloblastic anemia, teratogenicity
Sulfadoxine-Pyrimethamine	Antifolate combination	Blood schizont	IPTp; chloroquine-resistant malaria	Stevens-Johnson syndrome
Atovaquone-Proguanil	Mitochondria inhibitor + DHFR	Blood + liver schizont	Prophylaxis; treatment	GI, expensive
Doxycycline	Tetracycline	Blood schizont (slow)	Prophylaxis; with quinine for treatment	Photosensitivity, GI; avoid in pregnancy/children

DRUG GROUP 2: ANTIAMOEBIC DRUGS

Categories:

Luminal amoebicides - act in gut lumen; eliminate cysts and luminal trophozoites
Tissue amoebicides - penetrate tissues; kill invasive trophozoites
Mixed amoebicides - act on both

TYPE OF AMOEBIASIS          TREATMENT
─────────────────────────────────────────────────────────────────
Asymptomatic carrier        Luminal agent alone (diloxanide furoate)
                            (kill cysts to prevent spread)

Amoebic dysentery           Tissue agent (metronidazole) THEN
(invasive intestinal)       Luminal agent to eliminate cysts

Amoebic liver abscess       Tissue agent (metronidazole) THEN
                            Luminal agent (to eradicate gut reservoir)
                            Chloroquine can be added for liver abscess

METRONIDAZOLE - The Master Amoebicide

Also classified as: Nitroimidazole

Simple analogy: Metronidazole is like a Trojan horse. It enters the parasite looking harmless, but inside the parasite, it gets activated into a deadly weapon that slices the parasite's DNA to pieces.

Mechanism:

1. Metronidazole (PRODRUG) enters the amoeba/anaerobe
2. Inside the organism: the NITRO GROUP (-NO2) is REDUCED
   (by ferredoxin oxidoreductase in amoeba; by pyruvate:ferredoxin 
    oxidoreductase in anaerobic bacteria)
3. This creates TOXIC REACTIVE INTERMEDIATES (nitroso radicals)
4. These intermediates cause STRAND BREAKS in DNA
5. DNA is fragmented → cell death

Why it's selective: Human cells (aerobic) do NOT have the enzyme needed to reduce metronidazole to its toxic form. Amoeba and anaerobic bacteria DO have this reductase (they operate in low-oxygen environments).

Spectrum:

Entamoeba histolytica (amoeba)
Giardia lamblia
Trichomonas vaginalis
Anaerobic bacteria (Bacteroides, Clostridium, H. pylori)
Note: NOT effective against Entamoeba cysts or luminal forms well → must follow with a luminal agent

Clinical Uses:

Amoebic dysentery and amoebic liver abscess (drug of choice)
Giardiasis (drug of choice)
Trichomoniasis (drug of choice; treat partner simultaneously)
Anaerobic infections (B. fragilis, C. difficile, C. perfringens)
Helicobacter pylori eradication (part of triple/quadruple therapy)
Bacterial vaginosis

Adverse Effects:

Effect	Mechanism	Notes
Metallic taste in mouth	Direct effect on taste receptors	Very common, characteristic
Nausea, vomiting	GI irritation
Antabuse effect (Disulfiram-like reaction)	Inhibits aldehyde dehydrogenase	If alcohol consumed: flushing, nausea, vomiting, headache, palpitations; MUST AVOID ALCOHOL
Peripheral neuropathy	Neurotoxicity	With prolonged use
CNS effects	Confusion, seizures	High doses; rare
Urine darkening	Metabolite excretion	Harmless brown discoloration

Contraindications:

First trimester of pregnancy (potential teratogenicity; use with caution in 2nd/3rd trimester)
Avoid alcohol during use and for 48 hours after

Drug Interactions:

Warfarin: Metronidazole inhibits CYP2C9 → increases warfarin levels → bleeding risk; monitor INR
Lithium: increases lithium toxicity
Alcohol: disulfiram-like reaction

Resistance: Rare in amoeba; can occur in Trichomonas via reduced ferredoxin activity

TINIDAZOLE

Similar to metronidazole (also a nitroimidazole)
Longer half-life → single dose often effective
Better tolerated (less nausea)
Same mechanism, spectrum, and precautions as metronidazole
Used for: giardiasis (single dose), trichomoniasis, amoebiasis

DILOXANIDE FUROATE - The Pure Luminal Agent

Mechanism: Directly cytotoxic to amoeba trophozoites in the gut lumen; exact mechanism uncertain
Use: Asymptomatic amoebic carriers (kills cysts to prevent spread); used AFTER metronidazole to eliminate gut cysts
Adverse effects: Flatulence (very common), mild GI upset; generally well tolerated
Minimal systemic absorption → acts only in gut lumen → cannot treat invasive disease
Important: Give after completing metronidazole course, not simultaneously

PAROMOMYCIN (Aminoglycoside)

A non-absorbable aminoglycoside antibiotic used as a luminal amoebicide
Also used for: Cryptosporidiosis (immunocompromised), Giardia, Leishmaniasis
Not systemically absorbed → acts in gut lumen
Adverse effects: GI upset

CHLOROQUINE FOR AMOEBIASIS

Used for amoebic liver abscess (as an adjunct to metronidazole)
Concentrates in liver tissue (remember its large volume of distribution)
Does NOT treat intestinal amoebiasis (no activity in gut lumen)

DRUG GROUP 3: ANTILEISHMANIAL DRUGS

3A. SODIUM STIBOGLUCONATE (Pentavalent Antimony)

Simple analogy: Leishmania parasites are like factories that run on a specific fuel (ATP produced by their own metabolic pathways). Sodium stibogluconate jams the machinery that processes this fuel, forcing the factory to shut down.

Mechanism:

Pentavalent antimony (Sb⁵⁺) is converted to trivalent antimony (Sb³⁺) inside the macrophage
Sb³⁺ inhibits leishmanial enzymes involved in:
- Glycolysis (sugar breakdown)
- Fatty acid oxidation
- ATP generation

Uses:

First-line treatment for all forms of leishmaniasis (where resistance not present)
IV or IM administration

Adverse Effects:

Pain at injection site
Nausea, vomiting, anorexia
Pancreatitis
Hepatotoxicity
Nephrotoxicity
Cardiotoxicity: QT prolongation, ST-T changes
Arthralgia and myalgia

3B. AMPHOTERICIN B (Liposomal formulation preferred)

Originally an antifungal drug (binds ergosterol in fungal membranes)
Leishmania also has ergosterol-like sterols in their membranes → amphotericin B binds and forms pores → cell lysis
Liposomal amphotericin B (AmBisome) is now the treatment of choice for visceral leishmaniasis in many countries (less toxic, more effective)
Adverse effects of conventional amphotericin B: nephrotoxicity, fever, chills, hypokalemia
Liposomal form: significantly less toxic

3C. MILTEFOSINE

First oral drug for visceral leishmaniasis
Mechanism: Inhibits phospholipid and sterol biosynthesis in Leishmania; also induces apoptosis-like death
Advantages: Oral route, single course of treatment
Adverse effects: GI (nausea, vomiting, diarrhea), teratogenic (DO NOT use in pregnancy; effective contraception required during and 5 months after treatment)

3D. PENTAMIDINE

Mechanism: Unknown; multiple effects including DNA damage and interference with polyamine synthesis
Used for: Cutaneous leishmaniasis (alternative); early-stage African trypanosomiasis (first-line for children in some settings); Pneumocystis jirovecii pneumonia prophylaxis (inhaled)
Adverse effects:
- Nephrotoxicity
- Hypoglycemia (damages pancreatic beta cells, initially causing insulin release) → later → diabetes
- Hypotension (IV administration)
- Cardiotoxicity (QT prolongation)
- Pancreatitis
- Pain at injection site (IM)

DRUG GROUP 4: ANTITRYPANOSOMAL DRUGS

African Trypanosomiasis (Sleeping Sickness)

Staging is critical: Treatment depends on which stage the disease is in.

STAGE 1 (Hemolymphatic - no CNS involvement):
├── T. brucei gambiense: Fexinidazole (oral) - now first line
│                        Pentamidine (alternative, especially children)
└── T. brucei rhodesiense: Suramin

STAGE 2 (Meningoencephalitic - CNS involved):
├── T. brucei gambiense: Fexinidazole (oral) + Nifurtimox-Eflornithine
│                        Combination Therapy (NECT) 
└── T. brucei rhodesiense: Melarsoprol (toxic but often only option)

SURAMIN

Mechanism: Inhibits multiple trypanosomal enzymes (glycolysis enzymes, reverse transcriptase)
Use: Early-stage (Stage 1) T. brucei rhodesiense; also used for T. brucei gambiense Stage 1
Parenteral only (IV)
Does NOT cross blood-brain barrier → cannot treat Stage 2 disease
Adverse effects: Nephrotoxicity, peripheral neuropathy, bone marrow suppression, fever, rash
Test dose required before full treatment (anaphylactic reactions possible)

MELARSOPROL (Organic arsenical)

Simple analogy: Melarsoprol is like a chemical soldier that fights the enemy in the brain - the most difficult territory. It's effective, but it causes collateral damage to friendly troops (the patient's own nervous system).

Mechanism:

Melarsoprol (prodrug)
→ Metabolized to MELARSEN OXIDE (active form)
→ Melarsen oxide reacts with TRYPANOTHIONE
  (unique molecule in trypanosomes - like their version of glutathione)
→ Forms a stable adduct → INHIBITS TRYPANOTHIONE REDUCTASE
→ Oxidative stress in the parasite → death

Why trypanothione is a good target: Humans use glutathione for antioxidant defense. Trypanosomes use trypanothione. Drugs targeting trypanothione reductase can theoretically spare human cells.

Use: Stage 2 (CNS) T. brucei rhodesiense (now largely replaced by NECT for gambiense)

Adverse Effects:

Reactive Encephalopathy (most serious): Occurs in 5-10% of patients, 9-11 days into treatment; 50% mortality in those who develop it. Caused by inflammatory response to dying parasites in the CNS. Prednisolone is given concurrently to reduce this risk.
Peripheral neuropathy
Hypertension
Myocardial damage
Nephrotoxicity
Hepatotoxicity
Intense pain and tissue necrosis if extravasated (given IV only, very carefully)

Resistance: Mutations in AQP2 (aquaglyceroporin) → reduced drug uptake

EFLORNITHINE

Mechanism: Inhibits ornithine decarboxylase (ODC) - an enzyme essential for polyamine synthesis
Polyamines are needed for trypanosome replication
Interesting: Human ODC is rapidly recycled (so eflornithine doesn't harm humans much); trypanosome ODC turns over slowly → drug accumulates in parasite
Use: T. brucei gambiense (Stage 2); now used in NECT combination
Adverse effects: Bone marrow suppression (leukopenia, thrombocytopenia), GI effects, seizures (rare)

FEXINIDAZOLE

A nitroimidazole (like metronidazole) - oral drug
Mechanism: Reduced by trypanosomal nitroreductase → toxic metabolites → DNA damage
First ORAL drug for BOTH stages of T. brucei gambiense sleeping sickness
Major advance because it replaces IV melarsoprol for many gambiense patients
Cannot be used in rhodesiense sleeping sickness

American Trypanosomiasis - Chagas Disease

NIFURTIMOX:

Mechanism: Generates reactive oxygen species inside T. cruzi; also inhibits trypanothione metabolism
Use: Chagas disease (both acute and chronic phase; less effective in chronic)
Adverse effects: Neurological (seizures, peripheral neuropathy), GI, anorexia, weight loss
Teratogenic

BENZNIDAZOLE:

Mechanism: Like nifurtimox, generates reactive intermediates; also covalently modifies parasite proteins and DNA
Use: Drug of choice for Chagas disease (preferred over nifurtimox in most regions)
Adverse effects: Peripheral neuropathy, rashes, GI, bone marrow suppression
Cure rates higher in acute phase than chronic phase

DRUG GROUP 5: DRUGS FOR TOXOPLASMOSIS

PYRIMETHAMINE + SULFADIAZINE

First-line treatment for toxoplasmic encephalitis and congenital toxoplasmosis.

Combined with Folinic acid (Leucovorin) to prevent bone marrow toxicity
Pyrimethamine inhibits parasite DHFR (folate synthesis)
Sulfadiazine inhibits DHPS (folate synthesis - earlier step)
Together: double blockade of folate synthesis → very effective
Folinic acid does not rescue the parasite (parasite cannot use preformed folate; humans can) → selectively reverses human toxicity without reducing efficacy

Why Leucovorin? Pyrimethamine causes megaloblastic anemia by reducing folate availability for human cells (bone marrow is most sensitive). Leucovorin (reduced folate) bypasses DHFR and replenishes folate in human cells - but because Toxoplasma cannot use preformed folate, this doesn't help the parasite.

Adverse effects:

Megaloblastic anemia (prevented by leucovorin)
Rash (especially sulfadiazine)
Nephrotoxicity (sulfadiazine crystals in urine; stay well hydrated)
Cytopenias

Alternatives:

Pyrimethamine + Clindamycin (for sulfa-allergic patients)
TMP-SMX (trimethoprim-sulfamethoxazole) - alternative
Atovaquone (for refractory cases)

Spiramycin: A macrolide antibiotic that concentrates in placental tissue. Used in early pregnancy when mother is acutely infected with T. gondii to prevent fetal transmission. Does NOT treat established fetal infection.

DRUG GROUP 6: OTHER ANTIPROTOZOALS

METRONIDAZOLE FOR GIARDIA AND TRICHOMONAS

(Mechanism already covered - same as for amoebiasis)

Giardiasis: Metronidazole 250mg TID x 5-7 days, OR tinidazole single dose Trichomoniasis: Metronidazole 2g single dose (or 500mg BD x 7 days); treat sexual partner simultaneously

NITAZOXANIDE

Mechanism: Inhibits pyruvate:ferredoxin oxidoreductase (PFOR) enzyme system → disrupts anaerobic energy metabolism
Broad spectrum: Giardia, Cryptosporidium, Entamoeba histolytica, some helminths, some viruses
Drug of choice for Cryptosporidiosis (especially in immunocompetent patients; limited efficacy in AIDS)
Oral; well tolerated
Adverse effects: GI, yellow discoloration of urine and sclerae (harmless)

ANTIPROTOZOALS - COMPREHENSIVE TABLE

Disease	Organism	Drug of Choice	Alternative
Uncomplicated P. falciparum malaria	P. falciparum	ACT (artemether-lumefantrine)	Atovaquone-proguanil; quinine + doxycycline
Severe malaria	P. falciparum	IV Artesunate	IV Quinine
P. vivax/ovale malaria	P. vivax, P. ovale	Chloroquine + Primaquine	ACT + Primaquine
P. malariae	P. malariae	Chloroquine alone	-
Malaria prophylaxis	-	Atovaquone-proguanil OR Doxycycline OR Mefloquine	Chloroquine (sensitive areas)
Amoebic dysentery	E. histolytica	Metronidazole → Diloxanide furoate	Tinidazole
Amoebic liver abscess	E. histolytica	Metronidazole → Diloxanide furoate	Chloroquine + Metronidazole
Asymptomatic amoebiasis	E. histolytica	Diloxanide furoate	Paromomycin
Giardiasis	G. lamblia	Metronidazole	Tinidazole (single dose); Nitazoxanide
Trichomoniasis	T. vaginalis	Metronidazole (both partners)	Tinidazole
Visceral leishmaniasis	L. donovani	Liposomal Amphotericin B OR Miltefosine	Sodium stibogluconate
Cutaneous leishmaniasis	L. tropica/major	Sodium stibogluconate	Pentamidine
African sleeping sickness Stage 1 (gambiense)	T. b. gambiense	Fexinidazole	Pentamidine
African sleeping sickness Stage 2 (gambiense)	T. b. gambiense	NECT (Nifurtimox + Eflornithine)	Fexinidazole
African sleeping sickness Stage 1 (rhodesiense)	T. b. rhodesiense	Suramin	-
African sleeping sickness Stage 2 (rhodesiense)	T. b. rhodesiense	Melarsoprol	-
Chagas disease	T. cruzi	Benznidazole	Nifurtimox
Toxoplasmosis (encephalitis/congenital)	T. gondii	Pyrimethamine + Sulfadiazine + Leucovorin	Pyrimethamine + Clindamycin
Toxoplasmosis in pregnancy (maternal)	T. gondii	Spiramycin (1st trimester)	Pyrimethamine + Sulfadiazine (after 14 weeks)
Cryptosporidiosis	C. parvum	Nitazoxanide	Paromomycin (immunocompromised)

SECTION 4: TEACH USING ANALOGIES

Masterclass Analogy Series

Analogy 1: CHLOROQUINE - The Rubbish Disposal Saboteur

The malaria parasite lives inside a red blood cell and eats the cell's hemoglobin (the protein that carries oxygen in blood). When the parasite digests hemoglobin, it produces a toxic waste product called heme - a bit like a car engine producing exhaust fumes.

Normally, the parasite converts this toxic "exhaust" into a harmless solid crystal called hemozoin - like converting toxic gas into an inert solid block. This is essential for survival.

Chloroquine enters the parasite's "exhaust processing plant" and BREAKS the machine that converts toxic exhaust into harmless solid. Now the parasite is drowning in its own toxic waste. The exhaust (heme) rips apart the parasite's membranes, and it dies.

Analogy 2: PRIMAQUINE - The Cave-Clearing Special Forces Unit

Most antimalarials are like regular soldiers who fight the enemy on the open battlefield (your blood). But in P. vivax malaria, some parasites are hiding in underground caves in the liver (these are called hypnozoites - sleeping forms). Regular soldiers can't reach the caves.

Primaquine is the special forces team that goes underground to clear out these hidden sleeping parasites. Without primaquine, the enemy can emerge from hiding months or years later and attack again (this is called a relapse).

The danger: Primaquine creates "burning chemicals" (oxidants) to kill the cave-dwellers. If your red blood cells lack the fire-extinguisher enzyme (G6PD), these burning chemicals will destroy your own blood cells too (hemolysis).

Analogy 3: METRONIDAZOLE - The Trojan Horse Bomb

Metronidazole enters the amoeba looking completely harmless (like a Trojan horse). But inside the amoeba, there is a special chemical environment (low oxygen, special enzymes called ferredoxin oxidoreductases) that ACTIVATES metronidazole, transforming it into a toxic chemical weapon.

This activated weapon then attacks and slices the amoeba's DNA to pieces. Since human cells (in normal aerobic conditions) can't activate metronidazole, they are safe. The amoeba's own chemistry accidentally arms the bomb that kills it.

Analogy 4: ARTEMISININ - The Iron-Triggered Booby Trap

The malaria parasite eats so much hemoglobin that it has large amounts of iron-containing waste (heme) floating around inside it.

Artemisinin is like a chemical booby trap that is activated specifically by iron. When it encounters the high-iron environment inside the malaria parasite, it explodes into free radicals that destroy everything around them - the parasite's membranes, proteins, and enzymes.

Normal human cells have very little free iron → the trap doesn't go off → humans are safe. The parasite is uniquely vulnerable because it has created the very conditions needed to trigger its own destruction.

Analogy 5: ANTIFOLATES - Cutting Off the Ammunition Supply

The malaria parasite makes its own "ammunition" for DNA production (folate → purines → DNA). Humans get folate from food. The parasite must manufacture everything from scratch.

Pyrimethamine + Sulfadoxine is like sending two separate strike teams:

Sulfadoxine blocks the first factory (DHPS enzyme) where raw materials are assembled
Pyrimethamine blocks the second factory (DHFR enzyme) where the assembly is completed
Both factories shut down → no more DNA ammunition → parasite cannot replicate → it dies

Since humans don't use these same factories (we get finished folate from diet), we're largely unaffected.

Analogy 6: MELARSOPROL - The Scorched Earth Army

Melarsoprol is the "scorched earth" treatment for sleeping sickness in the brain. It works - it kills trypanosomes in the brain - but it's like burning down the forest to kill the mice. The drug can cause severe brain inflammation, paralysis, and death in about 5-10% of patients.

Trypanothione is the parasite's unique "shield system." Melarsoprol specifically attacks and destroys this shield. Without their shield, trypanosomes die from oxidative stress. Since humans use a different shield system (glutathione), they are somewhat protected - but the drug is still toxic enough to require very careful monitoring.

Analogy 7: PYRIMETHAMINE + LEUCOVORIN - Saving the Patient Without Saving the Enemy

Pyrimethamine blocks the enzyme DHFR in both the parasite AND in human cells (bone marrow cells are very sensitive to folate depletion). So we give folinic acid (leucovorin) alongside to "rescue" the bone marrow.

Here's the elegant trick: Leucovorin is a pre-made form of folate that SKIPS DHFR entirely. Human cells can absorb and use it directly. But Toxoplasma cannot absorb pre-made folate from its environment - it must make folate from scratch. So leucovorin saves the patient's bone marrow without rescuing the parasite.

SECTION 5: STEP-BY-STEP CLINICAL REASONING

Case 1: Febrile Patient Returning from Sub-Saharan Africa

Patient: 28-year-old, just returned from Nigeria, 2-week history of fever, chills, and headache. Fever spikes every 48 hours. Splenomegaly on examination. Blood smear shows ring forms.

Clinical Reasoning:

Step 1: What organisms could cause this?

History of travel to sub-Saharan Africa + cyclical fever + splenomegaly + blood smear = MALARIA
Sub-Saharan Africa: predominantly P. falciparum (dangerous), also P. vivax, P. ovale
Blood smear with "ring forms" visible confirms Plasmodium species

Step 2: What species is it?

P. falciparum: Multiple ring forms per RBC, banana-shaped gametocytes, severe disease possible
P. vivax/P. ovale: Enlarge RBCs, Schüffner's dots, one ring per RBC
Confirmatory: Rapid diagnostic test (RDT) for P. falciparum antigen (HRP-2)

Step 3: Is the disease severe or uncomplicated? Severe malaria criteria (any one of):

Cerebral malaria (altered consciousness, coma)
Severe anemia (Hb < 7g/dL)
Respiratory distress
Hypoglycemia
Acute kidney injury
Circulatory collapse (shock)
Parasitemia > 5% (P. falciparum)
Abnormal bleeding
Jaundice

Step 4: Choose the drug

If UNCOMPLICATED P. falciparum:

WHO first-line: Artemisinin-Based Combination Therapy (ACT)
Most used: Artemether-Lumefantrine (Coartem) 3-day course
In chloroquine-sensitive areas (rare for P. falciparum): chloroquine

If SEVERE malaria:

IV Artesunate (drug of choice; superior to quinine in clinical trials)
If IV artesunate not available: IV/IM Quinine + Doxycycline
Monitor blood glucose (risk of hypoglycemia from quinine)
ICU management for complications

Step 5: Any species-specific additions?

P. vivax or P. ovale: MUST add Primaquine after blood stage treatment (for radical cure - kills hypnozoites and prevents relapse)
BUT: must check G6PD status FIRST before giving primaquine

Step 6: After treatment

Check parasitemia at 48h, 72h to confirm clearance
Monitor for adverse effects
Counsel on malaria prevention for future travel

Case 2: Traveler with Bloody Diarrhea

Patient: 35-year-old, returned from India 2 weeks ago, now has severe lower abdominal cramps, bloody mucoid diarrhea (10 episodes/day), low-grade fever. Stool microscopy shows trophozoites with ingested red blood cells.

Clinical Reasoning:

Step 1: What is the diagnosis?

Trophozoites with ingested RBCs = pathognomonic of Entamoeba histolytica
Diagnosis: Invasive intestinal amoebiasis (amoebic dysentery)
Must distinguish from Shigella dysentery (bacteria) - stool culture needed; but clinical urgency may require empirical treatment

Step 2: Is this intestinal or has it spread to liver?

Right upper quadrant pain? Hepatomegaly? Fever? → suspect liver abscess
Ultrasound liver if suspected
Liver abscess: single, large, right lobe, "anchovy sauce" contents

Step 3: Drug selection

Invasive intestinal amoebiasis: Metronidazole (400-800mg TID x 5-10 days)
After metronidazole: Diloxanide furoate (500mg TID x 10 days) to eliminate luminal cysts
Amoebic liver abscess: same - Metronidazole THEN Diloxanide furoate (aspiration if > 5cm, risk of rupture, or no response to drugs)

Step 4: Counsel the patient

Avoid alcohol with metronidazole
Watch for metallic taste (normal side effect)
Family members may also need screening if same food/water source
Stool hygiene, hand washing to prevent transmission

Case 3: AIDS Patient with Headache and Confusion

Patient: 42-year-old with known HIV, CD4 count 45 cells/µL (severely immunocompromised), presents with headache, confusion, and fever for 2 weeks. Brain MRI shows multiple ring-enhancing lesions.

Clinical Reasoning:

Step 1: What are the differential diagnoses in a severely immunocompromised patient with ring-enhancing brain lesions?

Toxoplasmic encephalitis (most common; >60% of cases)
CNS lymphoma
Tuberculoma
Cryptococcoma
CMV encephalitis

Step 2: How to distinguish?

Toxoplasma encephalitis: multiple lesions, responds to empirical treatment
Serology: Anti-Toxoplasma IgG positive (most HIV patients with toxoplasmic encephalitis are seropositive)
EMPIRICAL TREATMENT: Start anti-toxoplasma therapy and look for clinical improvement in 2-3 weeks (this is the standard diagnostic approach - if no improvement, biopsy for lymphoma)

Step 3: Treatment of toxoplasmic encephalitis

Pyrimethamine + Sulfadiazine + Leucovorin (first-line)
Duration: Acute phase 6 weeks, then maintenance/suppressive therapy until CD4 > 200 for 6 months
If sulfa allergy: Pyrimethamine + Clindamycin + Leucovorin

Step 4: Why leucovorin?

Pyrimethamine inhibits DHFR in human cells too → bone marrow suppression → anemia, leukopenia
Leucovorin (folinic acid) bypasses DHFR to rescue bone marrow
Dose: Leucovorin 15-25mg daily or 50mg 3x/week

Step 5: Prophylaxis

All HIV patients with CD4 < 100-200 cells/µL should receive TMP-SMX for primary prophylaxis against Toxoplasma (and Pneumocystis)

SECTION 6: MEMORY TOOLS

Master Mnemonics

Mnemonic 1: ANTIMALARIAL DRUG CLASSES - "QAT SDP"

"QAT SDP" - Quality Anti-malarials Today Show Drug Possibilities

Q = Quinoline (Chloroquine, Quinine, Mefloquine, Primaquine)
A = Artemisinins (Artesunate, Artemether, DHA)
T = Tetracyclines (Doxycycline - adjunct)
S = Sulfonamide combinations (Sulfadoxine-Pyrimethamine)
D = Diaminopyrimidines (Pyrimethamine, Proguanil)
P = Peroxides (Atovaquone-Proguanil combo)

Mnemonic 2: PRIMAQUINE - "PrimaG6PD"

PRIMAQUINE requires G6PD status check BEFORE use

"Prima donna needs a G6PD clearance before performing"

If G6PD deficient → HEMOLYSIS → DO NOT USE (or use cautiously with monitoring)

Mnemonic 3: CINCHONISM - "The TIN DEAF patients who got TOO MUCH quinine"

TIN DEAF:

Tinnitus
Interopsia (visual disturbances)
Nausea
Dizziness
Ear problems (deafness at high doses)
Abdominal pain
Flushing/fever

Mnemonic 4: METRONIDAZOLE SIDE EFFECTS - "MUTANT DAD"

Metallic taste
Urine darkening
Therapeutic window with antabuse (alcohol reaction!)
Anti-anaerobic
NeuroToxicity (peripheral neuropathy - prolonged use)
Teratogenic (1st trimester)
DNA damage mechanism
Antibiotics interaction (warfarin levels rise)
Disulfiram-like reaction with alcohol

Mnemonic 5: DRUGS THAT CANNOT BE USED IN PREGNANCY (Antimalarials)

"4 DEMONS fight pregnant women:"

Doxycycline - NO (teeth/bone in fetus)
Eflornithine - NO (teratogenic)
Mefloquine - avoid 1st trimester
Of note: Artemisinin - avoid 1st trimester
Nifurtimox - NO
Some antimonials - use with caution

SAFE in pregnancy: Chloroquine, Proguanil, Artesunate (2nd/3rd trimester for severe malaria), Quinine (with monitoring for hypoglycemia), Clindamycin

Mnemonic 6: TISSUE SCHIZONTICIDES vs BLOOD SCHIZONTICIDES

"PrimeTime ABC is Live on Blood"

Tissue schizonticides (liver stage):

Primaquine, Tafenoquine (also kill hypnozoites)
Atovaquone-proguanil (causal prophylactic)
Artemisinins (some activity)

Blood schizonticides (erythrocytic stage):

Most antimalarials: Chloroquine, Quinine, Mefloquine, Artemisinins, Lumefantrine

Only kills hypnozoites (radical cure): Primaquine, Tafenoquine

Mnemonic 7: GAMETOCIDAL DRUGS

"PRimary Gametocides, Pls Quit Quinine's failing"

PRimaquine (gametocidal for all species including P. falciparum)
Proguanil (weak gametocidal activity)
Quinine (for P. vivax, P. ovale - not P. falciparum)
Artemisinins (gametocidal activity - reduces transmission)

Memory Story: The Journey of a Malaria Parasite (and How Each Drug Stops It)

"Sporozoites are like tiny paratroopers dropped from a mosquito airplane. They land in the bloodstream and rush to the liver (their first base of operations). Proguanil and atovaquone are the air defenses that shoot them down before they can establish the base (causal prophylactics).

In the liver, they build hypnozoite bunkers. Primaquine is the only bomb that can destroy these bunkers. Chloroquine is useless here.

When they emerge from the liver as merozoites and attack red blood cells, the big war begins. Chloroquine, quinine, artemisinin - these are the main battlefield soldiers.

The artemisinins are the special forces - fast, lethal, acting on all blood stages. But they burn out quickly (short half-life). The partner drug (lumefantrine, piperaquine) is the slower, longer-lasting weapon that mops up survivors.

Some parasites become gametocytes - sexual forms that want to escape to a new mosquito. Primaquine is the gatekeeper that kills P. falciparum gametocytes before they can escape."

Comparison Tables for Rapid Revision

Chloroquine vs Primaquine vs Quinine - Key Differences

Feature	Chloroquine	Primaquine	Quinine
Class	4-aminoquinoline	8-aminoquinoline	Quinoline methanol
Primary target	Blood schizonts	Liver schizonts, hypnozoites, gametocytes	Blood schizonts
Kills hypnozoites?	NO	YES	NO
Route	Oral	Oral	Oral, IV
Half-life	1-2 months	4-7 hours	8-18 hours
Unique toxicity	Retinopathy	Hemolysis (G6PD deficiency)	Cinchonism, hypoglycemia
G6PD check needed?	NO	YES	NO
Safe in pregnancy?	YES	NO	With caution

Metronidazole vs Diloxanide Furoate

Feature	Metronidazole	Diloxanide Furoate
Type	Tissue amoebicide	Luminal amoebicide
Site of action	Tissues (liver, gut wall)	Gut lumen only
Kills cysts?	Poorly	YES
Kills trophozoites?	YES (invasive)	In gut lumen
Systemic absorption	YES	Minimal
Liver abscess	YES	NO
Asymptomatic carrier	NO (can't kill cysts well)	YES
Key side effect	Metallic taste, alcohol reaction	Flatulence

SECTION 7: EXAMINER'S CORNER

Most Tested Facts

Chloroquine mechanism: Blocks heme polymerization (NOT a cell wall drug)
Primaquine: ONLY drug for hypnozoites; G6PD check mandatory; radical cure of P. vivax/ovale
Cinchonism: Quinine/quinidine toxicity = tinnitus, headache, visual disturbances, nausea
Quinine hypoglycemia: Stimulates insulin secretion; monitor blood glucose
Artemisinin mechanism: Endoperoxide bridge activated by iron → free radicals
ACT = Artemisinin-Based Combination Therapy (WHO recommended for P. falciparum)
Metronidazole: Alcohol contraindicated (disulfiram-like reaction); works by DNA damage via reductive activation
Pyrimethamine + Sulfadiazine + Leucovorin = toxoplasmosis treatment
Leucovorin: Added to prevent marrow toxicity; doesn't rescue parasite because parasite can't absorb preformed folate
Melarsoprol: Reactive encephalopathy (5-10%); used with prednisolone; for Stage 2 rhodesiense sleeping sickness

Most Likely Essay Questions

"Describe the pharmacology of chloroquine including its mechanism of action, adverse effects, and the mechanism of resistance."
"Discuss the treatment of severe falciparum malaria. Include drug choices, mechanisms, and management of complications."
"Write an essay on the treatment of amoebiasis including the drugs used, their mechanisms of action, and rationale for combination therapy."
"Discuss the role of artemisinin and its derivatives in the treatment of malaria. Why is combination therapy essential?"
"Write notes on: (a) Drug treatment of toxoplasmosis in an AIDS patient (b) Role of folinic acid in treatment"

Most Likely Short Notes

Primaquine - mechanism, uses, toxicity
Drug of choice for P. vivax malaria with radical cure
Chloroquine resistance - mechanism and implications
Metronidazole - mechanism and adverse effects
Artemisinin-based combination therapy (ACT)
Treatment of amoebic liver abscess
Cinchonism
Treatment of sleeping sickness (stage 1 and 2)

Most Likely Viva Questions

"What is the drug of choice for severe malaria?"
- Answer: IV Artesunate (IV Quinine if artesunate unavailable)
"Why is primaquine not used alone for malaria?"
- Answer: It is a poor blood schizonticide; must combine with a blood schizonticide (chloroquine) to kill blood-stage parasites
"Why can't we use chloroquine for P. vivax radical cure?"
- Answer: Chloroquine is only a blood schizonticide; it cannot kill liver stage hypnozoites; primaquine is needed for radical cure
"What test must you do before giving primaquine?"
- Answer: G6PD (Glucose-6-phosphate dehydrogenase) level - to detect G6PD deficiency (risk of hemolysis)
"Why is leucovorin given with pyrimethamine?"
- Answer: Pyrimethamine inhibits DHFR in human cells causing megaloblastic anemia; leucovorin (folinic acid) bypasses DHFR and rescues bone marrow without rescuing the parasite (parasite cannot use preformed folate)
"What is the mechanism of chloroquine resistance?"
- Answer: Mutation in PfCRT gene → encodes a transporter protein in the food vacuole membrane → actively pumps chloroquine out of the food vacuole before it can accumulate to inhibitory concentrations
"What is the treatment for Stage 2 West African sleeping sickness (T. brucei gambiense)?"
- Answer: NECT (Nifurtimox-Eflornithine Combination Therapy) or Fexinidazole
"Name a drug that can cause hypoglycemia and explain why."
- Answer: Quinine - stimulates insulin secretion from pancreatic beta cells, causing hypoglycemia; especially dangerous in pregnancy and severe malaria

Most Likely MCQs

Q1: A patient with P. vivax malaria is treated with chloroquine. Three months later he has a relapse. The most likely reason is:

A. Chloroquine resistance
B. Reinfection
C. Failure to use primaquine to eradicate liver hypnozoites ✓
D. Incorrect dose of chloroquine

Q2: Drug of choice for amoebic liver abscess is:

A. Metronidazole ✓
B. Diloxanide furoate
C. Chloroquine
D. Paromomycin

Q3: Cinchonism is caused by:

A. Chloroquine
B. Artemether
C. Quinine ✓
D. Primaquine

Q4: Mechanism of action of metronidazole:

A. Inhibits cell wall synthesis
B. Reductive activation → DNA strand breaks ✓
C. Inhibits protein synthesis
D. Inhibits heme polymerization

Q5: Which drug is BOTH a tissue schizonticide AND kills hypnozoites in P. vivax?

A. Chloroquine
B. Quinine
C. Primaquine ✓
D. Mefloquine

Q6: Before prescribing primaquine, which test is essential?

A. Liver function test
B. Renal function test
C. G6PD level ✓
D. Blood glucose

Q7: A patient on metronidazole attends a wedding and drinks champagne. What will happen?

A. Seizures
B. Disulfiram-like reaction: flushing, nausea, vomiting, palpitations ✓
C. Hypoglycemia
D. Nothing

Q8: Drug used for prophylaxis AND treatment of P. falciparum malaria with NO need to continue after travel (can start and stop quickly):

A. Chloroquine
B. Mefloquine
C. Atovaquone-Proguanil (Malarone) ✓
D. Doxycycline

Q9: First-line treatment of toxoplasmosis encephalitis in AIDS patient:

A. Metronidazole
B. Pyrimethamine + Sulfadiazine + Leucovorin ✓
C. Chloroquine
D. Nitazoxanide

Q10: Melarsoprol is used in:

A. Cerebral malaria
B. Visceral leishmaniasis
C. Stage 2 East African sleeping sickness (T. brucei rhodesiense) ✓
D. Chagas disease

Common Traps Students Fall Into

Trap 1: "Chloroquine treats all malaria"

WRONG. P. falciparum is widely resistant to chloroquine. ACT is used for P. falciparum.

Trap 2: "Primaquine alone cures malaria"

WRONG. Primaquine is a POOR blood schizonticide. Always combine with chloroquine (for P. vivax/ovale).

Trap 3: "P. falciparum malaria can relapse"

WRONG. Only P. vivax and P. ovale have hypnozoites and can relapse. P. falciparum and P. malariae do not relapse (but P. malariae can persist for very long periods without treatment).

Trap 4: "Diloxanide furoate treats amoebic liver abscess"

WRONG. Diloxanide is only a LUMINAL agent. Use metronidazole for invasive disease including liver abscess.

Trap 5: "Primaquine can be used freely in pregnancy"

WRONG. Primaquine is CONTRAINDICATED in pregnancy (risk of hemolysis in G6PD-deficient fetus).

Trap 6: "Leucovorin helps the parasite survive too when treating toxoplasmosis"

WRONG. Parasites (like Toxoplasma) cannot use preformed folate from the environment. Leucovorin rescues human cells but NOT the parasite.

Trap 7: "IV Quinine is the drug of choice for severe malaria"

OUTDATED. IV Artesunate is now the gold standard for severe malaria (WHO guidelines).

Trap 8: "All antimalarials are contraindicated in pregnancy"

WRONG. Chloroquine is safe in all trimesters. Artesunate is used for severe malaria in pregnancy (risks of severe malaria outweigh drug risks).

SECTION 9: HIGH-YIELD REVISION SHEET

One-Page Emergency Revision Summary

MALARIA - KEY FACTS

Drug	Class	Use	Key Toxicity	Special Feature
Chloroquine	4-aminoquinoline	Sensitive malaria, SLE, amoebic abscess	Retinopathy, pruritus	Blocks heme polymerization
Primaquine	8-aminoquinoline	Radical cure P. vivax/ovale; gametocidal P. falciparum	Hemolysis (G6PD deficiency), methemoglobinemia	ONLY drug for hypnozoites; G6PD check MANDATORY
Quinine	Quinoline methanol	Severe malaria (now 2nd line), babesiosis	Cinchonism, hypoglycemia, QT prolongation	Stimulates insulin; cinchona bark origin
Artesunate (IV)	Sesquiterpene lactone peroxide	Severe malaria (FIRST LINE)	Embryotoxic (1st trimester)	Iron-activated endoperoxide; fastest-acting
Artemether-Lumefantrine	ACT	Uncomplicated P. falciparum	QT prolongation (lumefantrine)	WHO first-line for uncomplicated P. falciparum
Atovaquone-Proguanil	Mitoch. inhibitor + DHFR	Prophylaxis + treatment P. falciparum	GI, expensive	Can start 1-2 days before travel; stop 7 days after
Mefloquine	Quinoline methanol	Prophylaxis chloroquine-resistant	Neuropsychiatric	Very long half-life (21 days)
Doxycycline	Tetracycline	Prophylaxis + adjunct treatment	Photosensitivity	NO in pregnancy, children <8 years
Sulfadoxine-Pyrimethamine	Antifolate	IPTp; some P. falciparum	Stevens-Johnson syndrome	Double blockade DHPS + DHFR

AMOEBIASIS - KEY FACTS

Metronidazole: Tissue amoebicide (invasive intestinal disease, liver abscess); then follow with diloxanide furoate
Diloxanide furoate: Luminal amoebicide (asymptomatic carrier); used to eliminate cysts after metronidazole
Sequence: Metronidazole THEN diloxanide furoate (NOT simultaneously)
Metronidazole mechanism: Reductive activation → DNA strand breaks; prodrug activated by low-O2 organisms
Metronidazole + alcohol = disulfiram-like reaction (MUST AVOID ALCOHOL)

OTHER PROTOZOAL DISEASES - KEY FACTS

Disease	First-Line Drug	Remember
Giardiasis	Metronidazole	Also tinidazole (single dose)
Trichomoniasis	Metronidazole (both partners)	Single 2g dose; partner must be treated
Toxoplasmosis (CNS)	Pyrimethamine + Sulfadiazine + Leucovorin	Leucovorin prevents marrow toxicity without rescuing parasite
Visceral leishmaniasis	Liposomal Amphotericin B or Miltefosine	Miltefosine = first ORAL anti-leishmanial; teratogenic
Sleeping sickness Stage 1 (gambiense)	Fexinidazole	New oral drug; major advance
Sleeping sickness Stage 2 (gambiense)	NECT	Nifurtimox + Eflornithine combination
Sleeping sickness Stage 2 (rhodesiense)	Melarsoprol	Reactive encephalopathy 5-10%; give prednisolone
Chagas disease	Benznidazole	Better than nifurtimox in most regions
Cryptosporidiosis	Nitazoxanide	Limited efficacy in immunocompromised

MUST-KNOW MECHANISMS

Drug	Mechanism
Chloroquine	Inhibits heme polymerization (hemozoin formation)
Primaquine	Generates reactive oxygen species (mitochondrial damage)
Artemisinins	Iron-activated endoperoxide → free radicals → protein alkylation
Pyrimethamine	Inhibits dihydrofolate reductase (DHFR)
Sulfonamides	Inhibit dihydropteroate synthase (DHPS)
Metronidazole	Reductive activation (by ferredoxin) → DNA strand breaks
Melarsoprol	Inhibits trypanothione reductase
Eflornithine	Inhibits ornithine decarboxylase (polyamine synthesis)
Amphotericin B	Binds ergosterol-like sterols → membrane pores
Pentamidine	Unknown; multiple effects including DNA/mitochondria

MUST-KNOW TOXICITIES

Drug	Key Toxicity
Chloroquine	Retinopathy (irreversible, long-term), pruritus in dark-skinned
Primaquine	Hemolysis (G6PD deficiency), methemoglobinemia
Quinine	Cinchonism (tinnitus, headache, nausea, visual disturbances), hypoglycemia (stimulates insulin), QT prolongation
Mefloquine	Neuropsychiatric (nightmares, psychosis, depression)
Artemisinin	Embryotoxic (animal data), neurotoxicity at very high doses
Metronidazole	Metallic taste, alcohol reaction (disulfiram-like), peripheral neuropathy (prolonged)
Pyrimethamine	Megaloblastic anemia (folate depletion) → give leucovorin
Melarsoprol	Reactive encephalopathy (5-10%), peripheral neuropathy
Miltefosine	Teratogenic (contraception needed), GI
Pentamidine	Hypoglycemia → later diabetes, nephrotoxicity, QT prolongation

EXAM EMERGENCY FACTS

Only drug for hypnozoites = PRIMAQUINE (and tafenoquine)
G6PD check before = PRIMAQUINE (and tafenoquine)
Drug of choice severe malaria = IV ARTESUNATE
WHO first-line uncomplicated P. falciparum = ACT (artemether-lumefantrine)
Chloroquine + PRIMAQUINE = radical cure P. vivax/ovale
Amoebic dysentery/liver abscess = METRONIDAZOLE then diloxanide furoate
Metronidazole mechanism = reductive activation → DNA breaks (by low-O2 enzymes)
Toxoplasmosis treatment = Pyrimethamine + Sulfadiazine + LEUCOVORIN
Why leucovorin doesn't help parasite = parasite cannot absorb preformed folate
Melarsoprol serious toxicity = reactive encephalopathy (5-10%; give prednisolone)
Chloroquine resistance mechanism = PfCRT mutation → pumps drug out of food vacuole
Metronidazole + alcohol = disulfiram-like reaction (NEVER give together)
First oral drug for visceral leishmaniasis = MILTEFOSINE (teratogenic!)
First oral drug for sleeping sickness (both stages gambiense) = FEXINIDAZOLE
Cinchonism = quinine toxicity: tinnitus, headache, visual disturbances, nausea, dizziness

SECTION 10: SELF-ASSESSMENT

10 Short-Answer Questions with Explanations

Question 1: A 22-year-old male traveler from Nigeria presents with cyclical fever. Blood smear confirms P. vivax malaria. He is started on chloroquine and improves. Why must primaquine be added, and what precaution is required before giving it?

Answer: P. vivax has a dormant liver stage called hypnozoites that can persist for months to years and cause relapses. Chloroquine only kills blood-stage parasites (blood schizonts). It cannot kill hypnozoites. Primaquine is the only drug that kills hypnozoites, and is required for "radical cure" - meaning permanent cure without relapse. Before giving primaquine, a G6PD (Glucose-6-phosphate dehydrogenase) level must be checked. If the patient has G6PD deficiency, primaquine will generate oxidative stress in red blood cells that CANNOT be neutralized (because the neutralizing enzyme G6PD is absent/deficient), causing hemolytic anemia - potentially severe.

Question 2: Explain the mechanism of chloroquine resistance in P. falciparum. Why does resistance not occur easily with artemisinins?

Answer: Chloroquine resistance in P. falciparum is due to mutations in the PfCRT (P. falciparum chloroquine resistance transporter) gene. The mutant PfCRT protein actively pumps chloroquine out of the parasite's food vacuole (where the drug needs to accumulate to inhibit heme polymerization). As a result, chloroquine cannot reach inhibitory concentrations and the parasite survives.

Artemisinins act differently - they are activated by free iron (heme) inside the parasite to generate reactive free radicals that alkylate multiple proteins simultaneously. Resistance to artemisinins (via K13 mutations) is emerging but is harder to develop because the drug damages many targets at once. This is also why combination therapy (ACT) is critical - the partner drug kills any artesunate-surviving parasites.

Question 3: Why is metronidazole not effective against Entamoeba histolytica cysts, and what drug should be used to eliminate cysts?

Answer: Metronidazole is a tissue amoebicide - it is well absorbed systemically and works best in tissues where oxygen tension is low (allowing reductive activation by ferredoxin). The gut lumen (where cysts reside) has relatively higher oxygen, and metronidazole concentrations in the lumen may not be adequate to reliably kill cysts. More importantly, cysts are the hardy, dormant form of the parasite with a thick protective wall, and are less metabolically active, making them less susceptible to metronidazole.

Diloxanide furoate (or paromomycin) is the drug of choice for luminal amoebiasis and asymptomatic carriage. It acts directly in the gut lumen to kill both trophozoites and cysts and is minimally absorbed, concentrating its action where it's needed. After completing metronidazole for invasive disease, a 10-day course of diloxanide furoate should always follow to eliminate the luminal reservoir and prevent reinfection and spread.

Question 4: A patient with AIDS and CD4 count of 50 cells/µL is found to have ring-enhancing brain lesions. What is the most likely diagnosis and what is the treatment?

Answer: The most likely diagnosis is toxoplasmic encephalitis (cerebral toxoplasmosis), caused by reactivation of Toxoplasma gondii in an immunocompromised patient. With CD4 < 100, Toxoplasma is the most common cause of focal brain lesions in HIV-positive patients.

Treatment: Pyrimethamine + Sulfadiazine + Leucovorin (Folinic acid)

Pyrimethamine inhibits Toxoplasma DHFR (dihydrofolate reductase)
Sulfadiazine inhibits Toxoplasma DHPS (dihydropteroate synthase)
Together they produce double blockade of folate synthesis → pyrimidines can't be made → parasite can't replicate
Leucovorin is added to prevent pyrimethamine-induced megaloblastic anemia in the patient (it rescues human bone marrow without rescuing the parasite, because Toxoplasma cannot absorb preformed folate)

Duration: 6 weeks acute treatment, then maintenance therapy until CD4 > 200 cells/µL for >6 months on antiretroviral therapy.

Question 5: A patient is prescribed quinine for malaria. List three important adverse effects and explain the mechanism of each.

Answer:

Cinchonism: Quinine accumulates in various tissues and interferes with cochlear hair cell function and the CNS, causing tinnitus (ringing in ears), headache, dizziness, nausea, and visual disturbances (blurred vision, altered color perception). This is dose-related and partially reversible.
Hypoglycemia: Quinine directly stimulates insulin secretion from pancreatic beta cells (by closing KATP channels in beta cells, mimicking the effect of elevated glucose). This causes excessive insulin release → blood glucose drops → hypoglycemia. This is particularly dangerous in: (a) pregnant women, who already tend toward hypoglycemia; (b) children; (c) patients with severe malaria (who are already prone to hypoglycemia from parasite consumption of glucose). Blood glucose must be monitored regularly during IV quinine treatment.
QT prolongation and cardiac arrhythmias: Quinine blocks cardiac potassium channels (IKr), prolonging the QT interval on ECG. This can predispose to serious ventricular arrhythmias including torsades de pointes (a potentially fatal arrhythmia). Risk is higher with IV administration and with higher plasma concentrations.

Question 6: What is the mechanism of action of artemisinins? Why are they used in combination (ACT) rather than alone?

Answer:

Mechanism: Artemisinins contain an endoperoxide bridge (–O–O– linkage) in their structure. When artemisinins enter the malaria parasite's food vacuole, they come into contact with large amounts of free iron (released during hemoglobin digestion). The iron reacts with the endoperoxide bridge in a Fenton-type reaction, breaking it open and generating highly reactive carbon-centered free radicals. These free radicals then alkylate (covalently bind to and damage) critical parasite proteins - including hemoglobin-digesting enzymes (falcipains, plasmepsins), the SERCA pump (PfATP6), and mitochondrial membrane components. Multiple targets are damaged simultaneously → parasite dies rapidly.

Why combination?

Short half-life: Artemisinins have a very short half-life (1-3 hours). When given alone, they cannot maintain adequate plasma levels long enough to kill all parasites. Recrudescence (return of infection) is common.
Resistance prevention: A small number of parasites may survive a single artemisinin course. The partner drug (lumefantrine, piperaquine, etc.) with its longer half-life continues to eliminate these survivors, preventing resistance from developing.
The combination provides rapid initial killing (artemisinin) + prolonged parasite clearance (partner drug).

Question 7: Compare the treatment of early-stage vs late-stage African sleeping sickness caused by T. brucei gambiense.

Answer:

Feature	Stage 1 (Hemolymphatic)	Stage 2 (Meningoencephalitic)
CNS involvement	No	Yes (parasites cross blood-brain barrier)
First-line drug	Fexinidazole (oral)	NECT (Nifurtimox + Eflornithine) or Fexinidazole
Alternative	Pentamidine (IM) in children <6 years or <20 kg	-
Key difference	Treatment is easier; oral drug available	Drugs must penetrate CNS; melarsoprol (highly toxic) was historically used

NECT (Nifurtimox-Eflornithine Combination Therapy):

Eflornithine inhibits ornithine decarboxylase → disrupts polyamine synthesis in trypanosomes → cell death
Nifurtimox generates reactive oxygen species → oxidative damage to trypanosomes
Together they are synergistic and are safer than melarsoprol

Fexinidazole is now a breakthrough oral drug active against BOTH stages of T. brucei gambiense - a major clinical advance as it replaces complex IV regimens for many patients.

For T. brucei rhodesiense (East African): Stage 1 = Suramin; Stage 2 = Melarsoprol (only option; much more toxic).

Question 8: Why should you never give alcohol to a patient taking metronidazole? What is this reaction called?

Answer: This is called the Disulfiram-like reaction (also called the antabuse reaction).

When alcohol is consumed, it is metabolized in the liver:

Alcohol → Acetaldehyde (toxic) → Acetate (harmless)
         [Alcohol               [Aldehyde
          dehydrogenase]         dehydrogenase]

Metronidazole inhibits aldehyde dehydrogenase (the second enzyme). This causes acetaldehyde to accumulate. Acetaldehyde is toxic and causes:

Flushing (face turns red)
Throbbing headache
Nausea and vomiting
Palpitations and tachycardia
Hypotension
Severe discomfort

This reaction can occur even with small amounts of alcohol (including alcohol in cough syrups, mouthwashes, some foods). Patients must be counseled to strictly AVOID ALCOHOL for the duration of treatment AND for 48 hours after stopping metronidazole (the drug and its active metabolites persist for this period).

Question 9: What is the difference between "radical cure" and "clinical cure" in malaria?

Answer:

Clinical cure means eliminating all blood-stage parasites so the patient feels better and has no more symptoms or fever. It does NOT mean the infection is permanently gone.

Radical cure means eliminating ALL stages of the parasite from the body - including dormant liver stages (hypnozoites in P. vivax and P. ovale) - to prevent future relapses.

Term	What's eliminated	Drugs needed
Clinical cure	Blood-stage parasites only	Blood schizonticide (e.g., chloroquine)
Radical cure	Blood stages + hypnozoites	Chloroquine + PRIMAQUINE

Why this distinction matters:

P. falciparum and P. malariae do NOT have hypnozoites → clinical cure = radical cure (no additional drug needed)
P. vivax and P. ovale HAVE hypnozoites → clinical cure ≠ radical cure → MUST add primaquine for radical cure to prevent relapses (which can occur months to years later)

Question 10: A patient who is a known G6PD-deficient individual is diagnosed with P. vivax malaria. How do you manage this clinical dilemma?

Answer:

This is a genuine clinical dilemma because:

P. vivax needs primaquine for radical cure (to kill hypnozoites and prevent relapses)
Primaquine causes hemolytic anemia in G6PD-deficient individuals
BUT without primaquine, relapses will occur (sometimes monthly)

Management strategy:

Treat acute attack: Chloroquine for blood-stage parasites (as usual). This is safe in G6PD deficiency.
For radical cure in G6PD deficiency:
- Mild deficiency (like African variant): Primaquine 0.75 mg/kg once WEEKLY for 8 weeks (lower, weekly dose with close monitoring for hemolysis is safer than daily dose)
- Severe deficiency (like Mediterranean or Asian variant): Primaquine is generally CONTRAINDICATED; accept the risk of relapses and treat each relapse with chloroquine, OR weigh benefit vs risk carefully with specialist supervision
Monitoring during primaquine therapy in G6PD deficiency:
- Measure hemoglobin/hematocrit before each weekly dose
- Watch for: dark urine (hemoglobinuria = sign of hemolysis), pallor, jaundice, fatigue
- Stop primaquine immediately if signs of significant hemolysis
Tafenoquine (newer 8-aminoquinoline) is an alternative for radical cure but is ALSO contraindicated in G6PD deficiency (causes more severe hemolysis than primaquine). G6PD level must still be checked before tafenoquine.

Sources: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th Edition; Katzung's Basic and Clinical Pharmacology, 16th Edition; Harrison's Principles of Internal Medicine, 22nd Edition; Goldman-Cecil Medicine; Medical Microbiology 9th Edition.

---Your complete Antiprotozoal Drugs learning note is ready above. Here is what was covered:

What This Note Contains

Section 1 - Big Picture: Why protozoal infections are uniquely challenging, and what antiprotozoal drugs are trying to achieve.

Section 2 - Foundation: Complete background on protozoan biology (eukaryotes vs prokaryotes - why this matters for drug design), the full malaria life cycle with drug target mapping, amoebiasis life cycle and tissue vs luminal distinction, giardiasis, leishmaniasis, trypanosomiasis (African and American), and toxoplasmosis.

Section 3 - Drug Framework: All major drug classes covered systematically:

Antimalarials: Chloroquine, Primaquine, Quinine, Mefloquine, Artemisinins/ACT, Antifolates (Pyrimethamine, Proguanil, Fansidar), Atovaquone-Proguanil
Antiamoebics: Metronidazole, Tinidazole, Diloxanide furoate, Paromomycin
Antileishmanials: Sodium stibogluconate, Liposomal Amphotericin B, Miltefosine, Pentamidine
Antitrypanosomals: Suramin, Melarsoprol, Eflornithine, Fexinidazole, NECT, Benznidazole, Nifurtimox
Anti-toxoplasma: Pyrimethamine + Sulfadiazine + Leucovorin, Spiramycin

Section 4 - Analogies: 7 memorable analogies (Chloroquine as rubbish disposal saboteur, Primaquine as cave-clearing special forces, Metronidazole as Trojan horse bomb, Artemisinin as iron-triggered booby trap, etc.)

Section 5 - Clinical Reasoning: Three full worked clinical cases (severe malaria, amoebic dysentery, AIDS with brain lesions)

Section 6 - Memory Tools: Mnemonics, comparison tables, drug vs disease tables, a complete memory story of the malaria life cycle

Section 7 - Examiner's Corner: Top 10 tested facts, common essay questions, short note topics, viva Q&A, 10 MCQs, and 8 common student traps

Section 9 - High-Yield Revision Sheet: Complete one-page summary with all must-know drugs, mechanisms, toxicities, and 15 exam emergency facts

Section 10 - Self-Assessment: 10 clinical short-answer questions with detailed explanations

This is a shared conversation. Sign in to Orris to start your own chat.